Diurnal Group PLC Posting of Annual Report and AGM Notice (4845T)
13 October 2017 - 7:00PM
UK Regulatory
TIDMDNL
RNS Number : 4845T
Diurnal Group PLC
13 October 2017
13 October 2017
Diurnal Group plc
("Diurnal" or the "Company")
Posting of Annual Report and AGM Notice
Diurnal Group plc (AIM: DNL), the specialty pharmaceutical
company targeting patient needs in chronic endocrine (hormonal)
diseases, announces that its Annual Report and Accounts for the
year ending 30 June 2017, together with the notice of Annual
General Meeting (AGM), have today been posted to shareholders.
The documents are being made available at the investor relations
section of the Company's website, www.diurnal.co.uk.
The Company's AGM will be held at 11.30am at the offices of FTI
Consulting LLP, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD
on Tuesday 21 November 2017.
For further information, please visit www.diurnal.co.uk
or contact:
+44 (0)20 3727
Diurnal Group plc 1000
Martin Whitaker, Chief Executive
Officer
Richard Bungay, Chief Financial
Officer
Numis Securities Ltd (Nominated +44 (0)20 7260
Adviser) 1000
Nominated Adviser: Michael Meade,
Paul Gillam, Freddie Barnfield
Corporate Broking: James Black
Panmure Gordon (UK) Limited (Joint +44 (0) 20 7886
Broker) 2500
Corporate Finance: Freddy Crossley
/ Duncan Monteith
Corporate Broking: Tom Salvesen
+44 (0)20 3727
FTI Consulting 1000
Simon Conway
Victoria Foster Mitchell
Notes to Editors
About Diurnal Group plc
Founded in 2004, Diurnal is a UK-based specialty pharma company
developing high quality products for the global market for the
life-long treatment of chronic endocrine conditions, including
Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its
expertise and innovative research activities focus on
circadian-based endocrinology to yield novel product candidates in
the rare and chronic endocrine disease arena.
For further information about Diurnal, please visit
www.diurnal.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBSBDGIXBBGRD
(END) Dow Jones Newswires
October 13, 2017 04:00 ET (08:00 GMT)
Diurnal (LSE:DNL)
Historical Stock Chart
From Apr 2024 to May 2024
Diurnal (LSE:DNL)
Historical Stock Chart
From May 2023 to May 2024